Caption Management, LLC Protagonist Therapeutics, Inc Put Options Transaction History

Caption Management, LLC

  • $5.74 Billion
  • Q3 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$33.72 - $47.33 $3.01 Million - $4.22 Million
89,200 New
89,200 $4.01 Million
Q2 2022

Aug 15, 2022
SELL
$7.06 - $25.52 $1.08 Million - $3.92 Million
-153,600 Reduced 65.75%
80,000 $633,000
Q4 2021

Feb 11, 2022
SELL
$17.63 - $37.1 $68,757 - $144,690
-3,900 Reduced 1.64%
233,600 $7.99 Million
Q3 2021

Nov 12, 2021
BUY
$12.95 - $49.69 $3.08 Million - $11.8 Million
237,500 New
237,500 $4.21 Million

Others Institutions Holding PTGX

# of Institutions
247
Shares Held
56.4M
Call Options Held
76.3K
Put Options Held
114K
View Full List

About Protagonist Therapeutics, Inc

PTGX Quotes by TradingView
  • Ticker PTGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,084,100
  • Market Cap $2.21B
  • Description
  • Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...
More about PTGX
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email